Clinical Trial Update: Optimal Dosage of Caspofungin in Critically Ill Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the optimal dosage of caspofungin in critically ill patients with suspected invasive candidiasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Candidiasis

Drugs mentioned

• Cancidas (caspofungin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Critically Ill, Suspected Invasive Candidiasis | Phase 4 | Status: COMPLETED